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Abstract: We report the development of a multiwell biosensor for detecting changes in the 
electrochemical open circuit potential (OCP) generated by viable human cells in vitro. The 
instrument features eight culture wells; each containing three gold sensors around a 
common silver/silver chloride reference electrode, prepared using screen-printed conductive 
inks. The potential applications of the device were demonstrated by monitoring rheumatoid 
synovial fibroblasts (RSF) and HepG2 hepatocarcinoma cells in response to chemical and 
biological treatments. This technology could provide an alternative to conventional   
end-point assays used in the fields of chemotherapy, toxicology and drug discovery. 
Keywords: Oncoprobe; electrochemical; biosensor; HepG2; cycloheximide; camptothecin 
 
1. Introduction 
We have previously reported the principles of an electrochemical biosensor, ‘Oncoprobe’, for 
passively recording the Electrochemical open circuit potential (OCP) of confluent cell monolayers on 
gold sensors in vitro and its application in anticancer drug testing [1-3]. The technology operates by 
monitoring the electrochemical potential generated at the microenvironment of the cell:sensor 
interface, measured relative to a reference electrode located in the bulk culture medium. Changes in 
cell behaviour, such as those induced by anticancer drugs, inflammatory cytokines or other agents 
were shown to modify the OCP of viable cells in vitro. 
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Whole-cell biosensors are currently receiving increased interest since they can provide real-time, 
non-invasive and label-free detection in applications such as drug discovery, toxicology and 
theranostics [4,5]. Conventional spectroscopy-based cell assays, such as MTT, designed to assess cell 
proliferation, metabolic changes or cytotoxicity are often reliant upon given end-points, and frequently 
involve destruction of the cells under analysis, as critically assessed in recent reports [6,7]. A major 
limitation of many conventional assays is that data is acquired at one specific time point, whereas 
many biological and cellular processes proceed over variable time courses in response to different 
extraneous stimuli/ligands. Biosensor technologies have been developed to overcome the limitations of 
these assays and several approaches have been taken to achieve this; including impedance [8], quartz 
crystal microbalance [9,10], optical [11], ion selective [12] and electrochemical methods [13] of 
detection. Here we report on developments on the original assay design, whereby the solid gold 
electrodes (sensors) and calomel reference electrodes previously employed have been replaced with a 
miniaturised disposable ceramic probe with screen-printed gold sensors and silver/silver chloride 
reference electrodes suitable for an eight-well assay device. We demonstrate the application of the 
technology using in vitro cell cultures of synovial fibroblasts and the human hepatocellular carcinoma 
cell line, HepG2. 
2. Results and Discussion 
2.1. Oncoprobe Equipment 
Figure 1 shows the 8-well cell culture assembly connected to the analytical monitor unit. The 
disposable ceramic probe, which forms the base of the culture assembly, is illustrated in Figure 2. 
Biocompatibility and suitability of all the components of the bioassay device was tested, particularly 
the interaction of cells with the gold substratum. Demonstrated in Figure 3 by the adherence of human 
breast carcinoma cells (8701-BC) to the gold sensor as judged by scanning electron microscopy, 24 h 
after seeding; such attachment of viable cells being essential for the generation of an electrochemical 
signal (OCP). These cells have previously been shown to adhere to solid gold sensors [1] and 
successfully attached to the screen printed conductive ink gold sensors employed here. 
Figure 1. Oncoprobe instrument: Analytical monitor and 8-well cell culture assembly. 
 Sensors 2010, 10                                       
 
 
3734
Figure 2. Disposable ceramic probe featuring gold sensors/tracking/contacts, reference 
electrode and insulating dielectric layer. 
 
Figure 3. Scanning electron micrograph of human 8701-BC cells on a screen-printed, 
conductive gold electrode (sensor). Bar = 12 µm. (Courtesy of Prof. T.D. Allen, PICR, 
Manchester, UK). 
 
The Oncoprobe instrument has developed through a number of key design features. Progression 
from an independent single well prototype unit to a disposable multiwell device; miniaturisation, 
which has allowed the number of cells and amount of media required per assay to be significantly 
reduced and the screen printing manufacturing process employed confers a high degree of 
reproducibility and reliability. Temperature and pH, factors we have previously shown to be important 
to the OCP signal obtained from sensors, have benefitted from greater stability due to operation within 
the controlled environment of a CO2 incubator [1]. In addition to the hardware developments, the 
polarity of the OCP displayed has been reversed from our earlier work [1,2], i.e., a more positive 
potential represents a more reducing state, whereas a more negative potential represents a more 
oxidising state. This enables us to attribute the changes in OCP observed definitively, hence a 
reduction in OCP now equates to a ‘loss’ of signal. Despite this change, the principal of the biosensor Sensors 2010, 10                                       
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system remains the same; variations in the OCP of adherent cells on the gold sensors reflect changes in 
cell behaviour. 
2.2. Electrochemical Monitoring of Cell Behaviour 
Unlike conventional sensors, in whole cell biosensors such as the Oncoprobe system the cells form 
the active sensing layer. This provides the opportunity to not only assay cells from an individual 
against certain treatments, e.g., in chemosensitivity or drug resistance testing, but also for drug 
discovery or toxicology applications, whereby a target cell type or line could have candidate 
compounds screened against it. 
Figure 4. (a) Real-time monitoring of the OCP of rheumatoid synovial fibroblasts showing 
the effects of cycloheximide and TNFα/IL-1β (mean values from 6 sensors for each 
treatment). (b) Photomicrographs showing the morphology of control (A), TNFα/IL-1β (B) 
and cycloheximide (C) -treated cells after 18h. Bar = 20 µm. 
 
Figure 4a shows the real-time monitoring of confluent layers of fibroblasts over 18h with and 
without treatments of cycloheximide or IL-1β/TNFα. Exposure to the latter is known to stimulate 
cellular activity and the OCP value is shown to be elevated over that of the control untreated cells. By 
contrast, cycloheximide (a known inhibitor of protein synthesis) is seen to suppress the OCP value of 
the cells. Thus, the electrochemical monitoring clearly discriminates between ‘activated’ and 
‘compromised’ cells relative to the untreated controls. Confirmation that the treatments used in   
Figure 4a were non-toxic and cells remained adherent is demonstrated by the photomicrographs in 
Figure 4b; the cellular morphology observed for some cells exposed to TNFα/IL-1β showing a typical 
dendritic/stellate appearance (B in Figure 4b) compared to control and cycloheximide-treated cells. Sensors 2010, 10                                       
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Figure 5. (a) Real-time electrochemical monitoring of the effect of camptothecin (CPT) on 
the OCP of HepG2 cells over 24 h (n = 6). (b) MTT assay data (absorbance ± SEM) from 
CPT treated HepG2 cells in parallel cultures after 24h (n = 6). 
 
To demonstrate that this electrochemical technology is applicable to different adherent cell types, 
OCP values have been monitored in experiments involving a variety of cell lines. Figure 5a shows the 
OCP profile for the human hepatocyte cell line, HepG2, and its response to camptothecin, a cytotoxic 
quinoline alkaloid that inhibits DNA topoisomerase I and induces apoptosis [14]. For a comparative 
study, the same cell line and camptothecin concentrations were examined by the conventional MTT 
assay after 24 h (Figure 5b). Both assays demonstrate the effects of camptothecin exposure, but while 
the end-point MTT assay shows the effect of the compound after 24h, the real-time bioelectrochemical 
monitoring of Figure 5a shows behavioural changes throughout the time course; with adherent cells 
present beyond 24 h (data not shown). 
In both the RSF and HepG2 electrochemical monitoring data (Figure 4a and Figure 5a) there is an 
initial period in which the signal takes time to settle. This is more pronounced in the cell-free sensors, 
suggesting that the presence of cells has a stabilising effect upon the signal. Analysis of the OCP 
generated by the confluent cell cultures prior to treatment (data not presented) showed that RSF 
generated a mean OCP of 112 mV (SD ± 7 mV) and HepG2 169 mV (SD ± 10 mV) whereas cell-free 
sensors produced 54 mV (SD ± 9 mV) and 6 mV (SD ± 17 mV) respectively. Therefore, cell-free 
sensors were not only more susceptible to variation but this was also dependent upon the culture  
media employed. Sensors 2010, 10                                       
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The multiwell Oncoprobe technology provides true real-time monitoring of the electrochemical 
signal. Therefore, quantitative data of the OCP observed can be defined over time, allowing a better 
understanding of the dynamic nature of cellular responses. The electrochemical reactions generating 
the OCP signal are yet to be conclusively defined but in our previous studies we have acknowledged 
the importance of redox and ionic changes at the cell:sensor interface, with dissolved oxygen 
concentration and pH values important factors [1,2]. Similarly, studies using scanning electrochemical 
microscopy (SECM) have also shown differences in the redox activity of normal and breast cancer 
cells [15]. Unlike impedance based biosensor technology [8,16,17] the flow of current in the 
Oncoprobe system is effectively negligible due to the high impedance employed. As such, the 
electrochemical monitoring of cell behaviour by this method is largely passive in comparison. 
The experiments using RSF and HepG2 cells reported here illustrate the advantages of real-time 
electrochemical analysis, whereby the effects of various ligands may be analysed over time without the 
need to define specific end-points. For example, in Figure 4, differences in the OCP of cytokine, 
cycloheximide and control RSF cultures can be observed after just four hours from treatment. 
Similarly, in HepG2 cells treated with the cytotoxic, apoptosis inducing agent camptothecin (Figure 5) 
differences in the OCP are apparent less than six hours into the experiment. 
The electrochemical OCP signal from confluent cultures of different cell lines have shown 
variations in the final plateaued value, which invites the question as to what processes contribute to the 
signal. Unlike RSF, which are restricted to confluent monolayers due to contact inhibition, cancer cell 
lines, although adherent to the gold sensors, may overgrow the single layer of cells, depending upon 
their proliferative rate. For this reason, the observations from parallel chamber slide cultures provide 
important information, not least an assessment of cell confluence and, if necessary, the fixation and 
staining of specific processes/proteins/morphology. Although the data presented is derived from 
adherent cell cultures that have reached confluence, earlier monitoring has the potential to provide 
information on cell attachment, spreading and proliferation rates. 
3. Experimental Section 
3.1. Oncoprobe Apparatus 
The Oncoprobe biosensor unit is comprised of an eight well culture assembly featuring a re-usable 
acrylic culture vessel with disposable ceramic probe attached to an analytical monitor. The disposable 
ceramic probe is sandwiched into the culture assembly with silicon o-ring seals and secured with 
stainless steel M3 bolts and screws. Each well contains three 1mm diameter gold sensors around a 
central 1mm diameter silver/silver chloride reference electrode manufactured using screen printed 
conductive inks (DuPont, Bristol, UK). Electrodes are then connected by gold tracking to the edges 
with a dielectric insulating layer printed above. The gold and dielectric layers were screen printed and 
each fired at 850 °C for 60 minutes, reference electrodes were printed over gold vias and fired at  
130 °C for 20 minutes. Gold-plated spring-loaded contacts (Coda Systems, Halstead, UK) interface the 
probe and analytical monitor via a bridging printed circuit board (PCB) embedded into the culture 
assembly. Silicon o-rings maintain an atmospheric seal between the analytical monitor and cell culture 
assembly. The analytical monitor was designed and manufactured for Oncoprobe Ltd. by Uniscan 
Instruments Ltd, Buxton, UK. Electrochemical open circuit potentials (OCP) generated at the Sensors 2010, 10                                       
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cell:sensor interface are measured and processed by the analytical monitor, then displayed in real-time 
via proprietary software on a personal computer. The high impedance measurement system results in a 
negligible current flow within the system of less than 10
–15 amps cm
–2. A sampling frequency of once 
every ten minutes was employed for all experiments. The Oncoprobe biosensor unit operates within an 
incubator at 37 °C, 5%CO2 in humidified air. 
3.2. Cell Cultures 
Human rheumatoid synovial fibroblasts (RSF) and 8701-BC breast carcinoma cells were cultured in 
Dulbecco’s modified eagles medium (DMEM) supplemented with 10% foetal bovine serum (FBS) and 
antibiotic/antimycotic, as previously described [1]. Human hepatocyte carcinoma (HepG2) cells 
(ECACC, Porton Down, UK) were maintained in Eagles’ minimal essential medium (EMEM) 
supplemented with 10% FBS. All three cell types were harvested using 0.2% trypsin solution (all 
Gibco, Paisley, UK), centrifuged and resuspended at the desired density after a haemocytometer cell 
count. Sterile Oncoprobes were assembled and pre-incubated with culture medium:10% FBS for   
2 hours before seeding cells. 
3.3. Scanning Electron Microscopy 
8701-BC cells were cultured on sections of the conductive gold ink coated ceramic probe. 
Following incubation overnight, samples were pre-fixed in 3% glutaraldehyde in Sorenson’s buffer 
(pH 7.4) for 1 hour, rinsed in buffer then post-fixed in 1% osmium tetroxide for 1 hour. After 
dehydration in ethanol and critical point drying by liquid CO2, 6 nm of chromium was sputter coated 
onto each section of ceramic probe. Specimens were viewed in a Topcon/ABT/ISI/DS130Fin lens, 
scanning electron microscope, as previously described [2]. 
3.4. Rheumatoid Synovial Fibroblasts (RSF) 
RSF cells were seeded into six Oncoprobe wells at a density of 5  10
4 cells well
–1 in a 300 µL 
volume, the remaining two wells received medium alone. Eight-well Lab-Tek II chamber slides (VWR 
Intl, UK) were prepared in parallel, with each well receiving 8  10
4 cells well
–1 in a 475 µL volume. 
Cultures were incubated overnight, adherence and confluence were then evaluated in the chamber 
slides before aspirating cell culture wells and replenishing with medium containing 30 µM 
Cycloheximide (Sigma, Poole, UK), 0.5 ng mL
–1 interleukin-1 beta (IL-1β) together with 20 ng mL
–1 
tumour necrosis factor alpha (TNFα) (R&D Systems, Abingdon, UK) in DMEM containing 2% FBS. 
Untreated RSF and cell-free controls received medium:FBS alone. Oncoprobe cultures were monitored 
for 18 h. Chamber slides containing treated and untreated control cells were fixed with 70% ethanol 
after 18 h, air-dried and stained with Harris’ Haematoxylin (Sigma, Poole, UK). Slides were viewed 
and photomicrographs taken with a Motic DM-BA300 digital photomicroscope system. 
3.5. HepG2 Toxicity Assay 
HepG2 cells in EMEM:10% FBS were seeded onto Oncoprobes at a density of 5  10
5 cells well
–1; 
cell-free control wells received media alone. Cells were also seeded into sterile 96-well plates (VWR, 
UK) at a density of 2  10
5 cells well
–1 for the 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium Sensors 2010, 10                                       
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bromide (MTT) based assay [18]. After incubating overnight, the wells were aspirated and treated with 
camptothecin (1–10 µM) in EMEM containing 2% FBS; HepG2 and cell-free controls received 
medium alone. Drug-induced effects were then monitored electrochemically for 24 h using the 
Oncoprobe system. The 96-well plates were assayed after 24h using an MTT based in vitro toxicology 
assay kit (Sigma, Poole, UK) as per the manufacturers’ instructions. Briefly, MTT solution was added 
to the cultures to a final concentration of 0.5 mg mL
–1 and incubated for 2 hours. The resulting 
formazan was then dissolved by adding an equal volume of 10% Triton X-100, 0.1N HCl in anhydrous 
isopropanol. Absorbance values were measured spectrophotometrically using a Dynex MRX II plate 
reader at 570 nm with a 690 nm background measurement. 
4. Conclusions 
This study has shown that the multiwell electrochemical monitoring technology demonstrated here 
can detect changes in the open circuit potential generated by cells in response to various factors; 
activation via cytokines, inhibition of protein synthesis and induction of apoptosis all cause significant 
modification in the OCP generated by the cells. As such, the system has shown potential applications 
in research, toxicology and theranostics. While the developments described in this publication have 
enhanced the potential of the technology in such fields, we recognise that further research and 
development is required to identify the mechanisms by which the OCP is generated and fully validate 
its efficacy. 
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